2013年中国宫颈癌的发病率和死亡率
Incidence and mortality of cervical cancer in China, 2013.
作者信息
Song Bingbing, Ding Chao, Chen Wangyang, Sun Huixin, Zhang Maoxiang, Chen Wanqing
机构信息
Tumor Prevention and Treatment Institute, Harbin Medical University, Harbin 150086, China.
Heilongjiang Academy of Medical Sciences, Harbin 150086, China.
出版信息
Chin J Cancer Res. 2017 Dec;29(6):471-476. doi: 10.21147/j.issn.1000-9604.2017.06.01.
OBJECTIVE
Estimating the incidence and mortality rate of cervical cancer became necessary to establish prevention measures and healthy policies. The aim of this study was to estimate the updated incidence and mortality rate of cervical cancer in 2013 in China.
METHODS
According to the evaluation criteria developed by the National Central Cancer Registry of China, the data submitted from 255 cancer registries met the required standards in 2013. Cervical cancer cases were retrieved from the national database and combined with the 2013 national population data. The age-standardized incidence and mortality rates were based on the demographic structure of the national census 2000 and Segi's world population.
RESULTS
In 2013, the estimated number of new cases and deaths from cervical cancer were 100,700 and 26,400, respectively. The crude incidence of cervical cancer was 15.17/100,000. The age-standardized incidence rates based on the Chinese standard population (ASIRC) and the world standard population (ASIRW) were 11.30/100,000 and 10.30/100,000, respectively. The incidence of cervical cancer in urban areas was 15.62/100,000 and the ASIRC was 11.12/100,000. The incidence of cervical cancer in rural areas was 14.65/100,000 and the ASIRC was 11.47/100,000. The mortality rate of cervical cancer was 3.98/100,000. The age-standardized mortality rates based on the Chinese (ASMRC) and world standard populations (ASMRW) were 2.76/100,000 and 2.62/100,000, respectively. The mortality rate of cervical cancer in urban areas was 3.85/100,000 and in rural areas was 4.14/100,000. Cervical cancer incidence and mortality increased with age. Urban areas had a higher incidence of cervical cancer and lower mortality rates when compared with rural areas.
CONCLUSIONS
Dynamic monitoring of cervical cancer incidence and mortality is the fundamental work of cervical cancer prevention and control. Cervical cancer is a serious issue in women's health, and prevention strategies need to be enhanced, such as human papilloma virus (HPV) vaccination and screening programs.
目的
估算宫颈癌的发病率和死亡率对于制定预防措施和健康政策很有必要。本研究的目的是估算2013年中国宫颈癌的最新发病率和死亡率。
方法
根据中国国家癌症中心制定的评估标准，2013年从255个癌症登记处提交的数据符合要求标准。从国家数据库中检索宫颈癌病例，并与2013年全国人口数据相结合。年龄标准化发病率和死亡率基于2000年全国人口普查的人口结构和Segi世界人口。
结果
2013年，估计宫颈癌新发病例数和死亡数分别为100700例和26400例。宫颈癌的粗发病率为15.17/10万。基于中国标准人口（ASIRC）和世界标准人口（ASIRW）的年龄标准化发病率分别为11.30/10万和10.30/10万。城市地区宫颈癌发病率为15.62/10万，ASIRC为11.12/10万。农村地区宫颈癌发病率为14.65/10万，ASIRC为11.47/10万。宫颈癌死亡率为3.98/10万。基于中国（ASMRC）和世界标准人口（ASMRW）的年龄标准化死亡率分别为2.76/10万和2.62/10万。城市地区宫颈癌死亡率为3.85/10万，农村地区为4.14/10万。宫颈癌发病率和死亡率随年龄增长而上升。与农村地区相比，城市地区宫颈癌发病率较高但死亡率较低。
结论
动态监测宫颈癌发病率和死亡率是宫颈癌防控的基础工作。宫颈癌是女性健康中的一个严重问题，需要加强预防策略，如人乳头瘤病毒（HPV）疫苗接种和筛查计划。
Zotero 插件